[1] |
Shimizu M, Wada T. Nephrotic syndrome in diabetic nephropathy and diabetes[J].Nihon Jinzo Gakkai Shi, 2014, 56(4): 500-509.
|
[2] |
Ichii O, Horino T. MicroRNAs associated with the development of kidney diseases in humans and animals[J]. J Toxicol Pathol, 2018, 31(1): 23-34.
|
[3] |
Kato M, Natarajan R. MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets[J]. Ann N Y Acad Sci, 2015, 1353(1): 72-88.
|
[4] |
高志强, 马云, 崔玉彬. 糖尿病肾病患者血清miR-200c与TGF-β_1、FN的相关性分析[J].山东医药, 2018, 58(14): 50-52.
|
[5] |
王彤, 于德民, 于珮. β2糖蛋白1对糖尿病小鼠肾脏组织转化生长因子β1表达的影响[J].中华糖尿病杂志, 2015, 7(2):1 15-119.
|
[6] |
杨烨, 张园园, 田燕燕, 等. 活性维生素D3对糖尿病肾病大鼠转化生长因子β1及相关因子的调节作用[J]. 中华内分泌代谢杂志, 2015, 31(1): 66-70.
|
[7] |
Chen J, Li D. Telbivudine attenuates UUO-induced renal fibrosis via TGF-β/Smad and NF-κB signaling[J]. Int Immunopharmacol, 2017, 55(1):1-8.
|
[8] |
Kato M, Natarajan R. Diabetic nephropathy--emerging epigenetic mechanisms[J]. Nat Rev Nephrol, 2014, 10(9): 517-530.
|
[9] |
Petrillo F, Iervolino A, Zacchia M, et al. MicroRNAs in renal diseases: a potential novel therapeutic target[J]. Kidney Dis (Basel), 2017, 3(3): 111-119.
|
[10] |
Bojmar L, Karlsson E, Elleqard S. The role of microRNA-200 in progression of human colorectal and breast cancer[ J]. PLoS One, 2013, 8(12): e84815.
|
[11] |
Djuranovic S, Nahvi A, Green R. A parsimonious model for gene regulation by miRNAs[J]. Science, 2011, 331(6017): 550-553.
|
[12] |
陈珺, 蔡晋宇, 杜翠, 等. MiR-200c与脏器纤维化的研究进展[J]. 中南大学学报(医学版), 2017, 42(02): 226-232.
|
[13] |
杨烨, 张园园, 田燕燕, 等. 活性维生素D3对糖尿病肾病大鼠转化生长因子β1及相关因子的调节作用[J]. 中华内分泌代谢杂志, 2015, 31(1): 66-70.
|
[14] |
陆美萍, 辛传伟, 杨明华, 等. 消渴平合剂对链脲佐菌素诱导的糖尿病肾病大鼠肾功能及miR-192的影响研究[J]. 中华中医药学刊, 2017, 35(5): 1285-1287, 1366.
|
[15] |
Kim BH, Lee ES, Choi R, et al. Protective effects of curcumin on renal oxidative stress and lipid metabolism in a rat model of type 2 diabetic nephropathy[J]. Yonsei Med J, 2016, 57(3): 664-673.
|
[16] |
Arora MK, Singh UK. Oxidative stress: meeting multiple targets in pathogenesis of diabetic nephropathy[J]. Curr Drug Targets, 2014, 15(5): 531-538.
|
[17] |
Lan T, Liu W, Xie X, et al. Berberine suppresses high glucose-induced TGF-β1 and fibronectin synthesis in mesangial cells through inhibition of sphingosine kinase 1/AP-1 pathway[J]. Eur J Pharmacol, 2012, 697(1-3): 165-172.
|
[18] |
Valladares-Salgado A, Angeles-Martínez J, Rosas M, et al. Association of polymorphisms within the transforming growth factor-β1 gene with diabetic nephropathy and serum cholesterol and triglyceride concentrations[J]. Nephrology (Carlton), 2010, 15(6): 644-648.
|